GSC
VNRX icon

Ground Swell Capital’s VolitionRx Ltd VNRX Stock Holding History

Ground Swell Capital’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,298
Closed -$27.6K – 264
2024
Q3 		$27.6K Buy
2,298
+1,012
+79% +$13K 0.02% 117
2024
Q2 		$15.6K Buy
+1,286
New +$18.8K 0.01% 141
2023
Q4 		– Sell
-531
Closed -$7.32K – 130
2023
Q3 		$7.32K Buy
+531
New +$13.1K 0.01% 73

Other funds holding VNRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ground Swell Capital's VNRX Position: Q4 2024 in Review

Ground Swell Capital sold out of VolitionRx Ltd (VNRX) in Q4 2024, closing a stake of 2,298 shares — an estimated $27.6K sold.

Ground Swell Capital first reported a position in VNRX in Q3 2023 and held it in 3 quarters. The position peaked at $27.6K in Q3 2024. 27 funds tracked by Wall St. Rank hold VNRX as of Q4 2024.

  • Ground Swell Capital reported no remaining VolitionRx Ltd position as of Q4 2024 after selling out during the quarter.
  • Ground Swell Capital sold 2,298 VolitionRx Ltd shares in Q4 2024, an estimated $27.6K.
  • Ground Swell Capital first reported a position in VolitionRx Ltd in Q3 2023 and held it in 3 quarters.
  • Ground Swell Capital's VolitionRx Ltd position peaked at $27.6K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2024.

Based on Ground Swell Capital's 13F filing for Q4 2024, filed 14 Feb 2025.